Psychopharmacology

, Volume 196, Issue 3, pp 377–387

A role for neuronal nicotinic acetylcholine receptors in ethanol-induced stimulation, but not cocaine- or methamphetamine-induced stimulation

Original Investigation

Abstract

Rationale

Cocaine (COC), ethanol (EtOH), and methamphetamine (MA) are widely abused substances and share the ability to induce behavioral stimulation in mice and humans. Understanding the biological basis of behavioral stimulation to COC, EtOH, and MA may provide a greater understanding of drug and alcohol abuse.

Objectives

In these studies we set out to determine if neuronal nicotinic acetylcholine receptors were involved in the acute locomotor responses to these drugs, our measure of behavioral stimulation.

Methods

A panel of acetylcholine receptor antagonists was used to determine if nicotinic receptors were involved in EtOH- and psychostimulant-induced stimulation. We tested the effect of these drugs in genotypes of mice (FAST and DBA/2J) that are extremely sensitive to this drug effect. To determine which acetylcholine receptor subunits may be involved in this response, relative expression of the α3, α6, β2, and β4 subunit genes was examined in mice selectively bred for high and low response to EtOH.

Results

Mecamylamine, but not hexamethonium, attenuated the acute locomotor response to EtOH. The acetylcholine receptor antagonist dihydro-β-erythroidine and methyllycaconitine had no effect on this response. The α6 and β4, but not α3 or β2, subunits of the acetylcholine receptor were differentially expressed between mice bred for extreme differences in EtOH stimulation. Mecamylamine had no effect on psychostimulant-induced locomotor activity.

Conclusions

Neuronal nicotinic receptors are involved in EtOH, but not psychostimulant, stimulation. These studies suggest a lack of involvement of some nicotinic receptor subtypes, but more work is needed to determine the specific receptor subtypes involved in this behavior.

Keywords

Methamphetamine Ethanol Cocaine Stimulation Nicotinic acetylcholine receptors Locomotor activity Selected lines 

References

  1. Amalric M, Koob GF (1993) Functionally selective neurochemical afferents and efferents of the mesocorticolimbic and nigrostriatal dopamine system. Prog Brain Res 99:209–226PubMedCrossRefGoogle Scholar
  2. Azam L, Winzer-Serhan UH, Chen Y, Leslie FM (2002) Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs within midbrain dopamine neurons. J Comp Neurol 444:260–274PubMedCrossRefGoogle Scholar
  3. Bergstrom HC, Palmer AA, Wood RD, Burkhart-Kasch S, McKinnon CS, Phillips TJ (2003) Reverse selection for differential response to the locomotor stimulant effects of ethanol provides evidence for pleiotropic genetic influence on locomotor response to other drugs of abuse. Alcohol Clin Exp Res 27:1535–1547PubMedCrossRefGoogle Scholar
  4. Blomqvist O, Soderpalm B, Engel JA (1992) Ethanol-induced locomotor activity: involvement of central nicotinic acetylcholine receptors? Brain Res Bull 29:173–178PubMedCrossRefGoogle Scholar
  5. Boehm SL 2nd, Schafer GL, Phillips TJ, Browman KE, Crabbe JC (2000) Sensitivity to ethanol-induced motor incoordination in 5-HT(1B) receptor null mutant mice is task-dependent: implications for behavioral assessment of genetically altered mice. Behav Neurosci 114:401–409PubMedCrossRefGoogle Scholar
  6. Boorman JP, Beato M, Groot-Kormelink PJ, Broadbent SD, Sivilotti LG (2003) The effects of beta3 subunit incorporation on the pharmacology and single channel properties of oocyte-expressed human alpha3beta4 neuronal nicotinic receptors. J Biol Chem 278:44033–44040PubMedCrossRefGoogle Scholar
  7. Broadbent S, Groot-Kormelink PJ, Krashia PA, Harkness PC, Millar NS, Beato M, Sivilotti LG (2006) Incorporation of the beta3 subunit has a dominant-negative effect on the function of recombinant central-type neuronal nicotinic receptors. Mol Pharmacol 70:1350–1357PubMedCrossRefGoogle Scholar
  8. Carboni E, Imperato A, Perezzani L, Di Chiara G (1989) Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience 28:653–661PubMedCrossRefGoogle Scholar
  9. Chi H, de Wit H (2003) Mecamylamine attenuates the subjective stimulant-like effects of alcohol in social drinkers. Alcohol Clin Exp Res 27:780–786PubMedCrossRefGoogle Scholar
  10. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159PubMedCrossRefGoogle Scholar
  11. Chomczynski P, Sacchi N (2006) The single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–cholorform extraction: twenty-something years on. Nat Protoc 1:581–585PubMedCrossRefGoogle Scholar
  12. Crabbe JC, Kosobud A, Young ER, Janowsky JS (1983) Polygenic and single-gene determination of responses to ethanol in BXD/Ty recombinant inbred mouse strains. Neurobehav Toxicol Teratol 5:181–187PubMedGoogle Scholar
  13. Crabbe JC, Young ER, Deutsch CM, Tam BR, Kosobud A (1987) Mice genetically selected for differences in open-field activity after ethanol. Pharmacol Biochem Behav 27:577–581PubMedCrossRefGoogle Scholar
  14. Crabbe JC, Gallaher ES, Phillips TJ, Belknap JK (1994) Genetic determinants of sensitivity to ethanol in inbred mice. Behav Neurosci 108:186–195PubMedCrossRefGoogle Scholar
  15. Cui C, Booker TK, Allen RS, Grady SR, Whiteaker P, Marks MJ, Salminen O, Tritto T, Butt CM, Allen WR, Stitzel JA, McIntosh JM, Boulter J, Collins AC, Heinemann SF (2003) The beta3 nicotinic receptor subunit: a component of alpha-conotoxin MII-binding nicotinic acetylcholine receptors that modulate dopamine release and related behaviors. J Neurosci 23:11045–11053PubMedGoogle Scholar
  16. Damaj MI, Kao W, Martin BR (2003) Characterization of spontaneous and precipitated nicotine withdrawal in the mouse. J Pharmacol Exp Ther 307:526–534PubMedCrossRefGoogle Scholar
  17. Di Chiara G, Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274–5278PubMedCrossRefGoogle Scholar
  18. Dick DM, Jones K, Saccone N, Hinrichs A, Wang JC, Goate A, Bierut L, Almasy L, Schuckit M, Hesselbrock V, Tischfield J, Foroud T, Edenberg H, Porjesz B, Begleiter H (2006) Endophenotypes successfully lead to gene identification: results from the collaborative study on the genetics of alcoholism. Behav Genet 36:112–126PubMedCrossRefGoogle Scholar
  19. Downing C, Carosone-Link P, Bennett B, Johnson T (2006) QTL mapping for low-dose ethanol activation in the LXS recombinant inbred strains. Alcohol Clin Exp Res 30:1111–1120PubMedCrossRefGoogle Scholar
  20. Dudek BC, Phillips TJ, Hahn ME (1991) Genetic analyses of the biphasic nature of the alcohol dose–response curve. Alcohol Clin Exp Res 15:262–269PubMedCrossRefGoogle Scholar
  21. Escubedo E, Chipana C, Perez-Sanchez M, Camarasa J, Pubill D (2005) Methyllycaconitine prevents methamphetamine-induced effects in mouse striatum: involvement of alpha7 nicotinic receptors. J Pharmacol Exp Ther 315:658–667PubMedCrossRefGoogle Scholar
  22. Gabbay FH (2005) Family history of alcoholism and response to amphetamine: sex differences in the effect of risk. Alcohol Clin Exp Res 29:773–780PubMedCrossRefGoogle Scholar
  23. Glick SD, Kuehne ME, Maisonneuve IM, Bandarage UK, Molinari HH (1996) 18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats. Brain Res 719:29–35PubMedCrossRefGoogle Scholar
  24. Glick SD, Maisonneuve IM, Dickinson HA (2000) 18-MC reduces methamphetamine and nicotine self-administration in rats. Neuroreport 11:2013–2015PubMedCrossRefGoogle Scholar
  25. Glick SD, Maisonneuve IM, Kitchen BA, Fleck MW (2002) Antagonism of alpha 3 beta 4 nicotinic receptors as a strategy to reduce opioid and stimulant self-administration. Eur J Pharmacol 438:99–105PubMedCrossRefGoogle Scholar
  26. Gommans J, Stolerman IP, Shoaib M (2000) Antagonism of the discriminative and aversive stimulus properties of nicotine in C57BL/6J mice. Neuropharmacology 39:2840–2847PubMedCrossRefGoogle Scholar
  27. Grisel JE, Belknap JK, O’Toole LA, Helms ML, Wenger CD, Crabbe JC (1997) Quantitative trait loci affecting methamphetamine responses in BXD recombinant inbred mouse strains. J Neurosci 17:745–754PubMedGoogle Scholar
  28. Groot-Kormelink PJ, Luyten WH, Colquhoun D, Sivilotti LG (1998) A reporter mutation approach shows incorporation of the “orphan” subunit beta3 into a functional nicotinic receptor. J Biol Chem 273:15317–15320PubMedCrossRefGoogle Scholar
  29. Imperato A, Di Chiara G (1986) Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol. J Pharmacol Exp Ther 239:219–228PubMedGoogle Scholar
  30. Izawa J, Yamanashi K, Asakura T, Misu Y, Goshima Y (2006) Differential effects of methamphetamine and cocaine on behavior and extracellular levels of dopamine and 3,4-dihydroxyphenylalanine in the nucleus accumbens of conscious rats. Eur J Pharmacol 549:84–90PubMedCrossRefGoogle Scholar
  31. Jerlhag E, Grotli M, Luthman K, Svensson L, Engel JA (2006) Role of the subunit composition of central nicotinic acetylcholine receptors for the stimulatory and dopamine-enhancing effects of ethanol. Alcohol Alcohol 41:486–493PubMedGoogle Scholar
  32. Kalivas PW, Nakamura M (1999) Neural systems for behavioral activation and reward. Curr Opin Neurobiol 9:223–227PubMedCrossRefGoogle Scholar
  33. Kamens HM, Burkhart-Kasch S, McKinnon CS, Li N, Reed C, Phillips TJ (2005) Sensitivity to psychostimulants in mice bred for high and low stimulation to methamphetamine. Genes Brain Behav 4:110–125PubMedCrossRefGoogle Scholar
  34. Kamens HM, Burkhart-Kasch S, McKinnon CS, Li N, Reed C, Phillips TJ (2006) Ethanol-related traits in mice selectively bred for differential sensitivity to methamphetamine-induced activation. Behav Neurosci 120:1356–1366PubMedCrossRefGoogle Scholar
  35. Khiroug SS, Khiroug L, Yakel JL (2004) Rat nicotinic acetylcholine receptor alpha2beta2 channels: comparison of functional properties with alpha4beta2 channels in Xenopus oocytes. Neuroscience 124:817–822PubMedCrossRefGoogle Scholar
  36. Klink R, de Kerchove d’Exaerde A, Zoli M, Changeux JP (2001) Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J Neurosci 21:1452–1463PubMedGoogle Scholar
  37. Larsson A, Svensson L, Soderpalm B, Engel JA (2002) Role of different nicotinic acetylcholine receptors in mediating behavioral and neurochemical effects of ethanol in mice. Alcohol 28:157–167PubMedCrossRefGoogle Scholar
  38. Larsson A, Jerlhag E, Svensson L, Soderpalm B, Engel JA (2004) Is an alpha-conotoxin MII-sensitive mechanism involved in the neurochemical, stimulatory, and rewarding effects of ethanol? Alcohol 34:239–250PubMedCrossRefGoogle Scholar
  39. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402–408PubMedCrossRefGoogle Scholar
  40. Maisonneuve IM, Glick SD (2003) Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatment. Pharmacol Biochem Behav 75:607–618PubMedCrossRefGoogle Scholar
  41. Marley RJ, Arros DM, Henricks KK, Marley ME, Miner LL (1998) Sensitivity to cocaine and amphetamine among mice selectively bred for differential cocaine sensitivity. Psychopharmacology (Berl) 140:42–51CrossRefGoogle Scholar
  42. Marubio LM, Gardier AM, Durier S, David D, Klink R, Arroyo-Jimenez MM, McIntosh JM, Rossi F, Champtiaux N, Zoli M, Changeux JP (2003) Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors. Eur J Neurosci 17:1329–1337PubMedCrossRefGoogle Scholar
  43. McClearn GE, Wilson SG, Meredith W (1970) The use of isogenic and heterogenic mouse stocks in behavioral research. In: Thiessen DD (ed) Contributions to behavior-genetic analysis: the mouse as a protoype. Appleton-Century-Crofts, New York, pp 3–22Google Scholar
  44. Meldgaard M, Fenger C, Lambertsen KL, Pedersen MD, Ladeby R, Finsen B (2006) Validation of two reference genes for mRNA level studies of murine disease models in neurobiology. J Neurosci Methods 156:101–110PubMedCrossRefGoogle Scholar
  45. National Research Council (1996) Guide for the care and use of laboratory animals. National Academy Press, Washington, DCGoogle Scholar
  46. Pace CJ, Glick SD, Maisonneuve IM, He LW, Jokiel PA, Kuehne ME, Fleck MW (2004) Novel iboga alkaloid congeners block nicotinic receptors and reduce drug self-administration. Eur J Pharmacol 492:159–167PubMedCrossRefGoogle Scholar
  47. Palmer AA, McKinnon CS, Bergstrom HC, Phillips TJ (2002) Locomotor activity responses to ethanol, other alcohols, and GABA-A acting compounds in forward- and reverse-selected FAST and SLOW mouse lines. Behav Neurosci 116:958–967PubMedCrossRefGoogle Scholar
  48. Phillips TJ, Burkhart-Kasch S, Terdal ES, Crabbe JC (1991) Response to selection for ethanol-induced locomotor activation: genetic analyses and selection response characterization. Psychopharmacology (Berl) 103:557–566CrossRefGoogle Scholar
  49. Phillips TJ, Huson MG, McKinnon CS (1998) Localization of genes mediating acute and sensitized locomotor responses to cocaine in BXD/Ty recombinant inbred mice. J Neurosci 18:3023–3034PubMedGoogle Scholar
  50. Phillips TJ, Shen EH, McKinnon CS, Burkhart-Kasch S, Lessov CN, Palmer AA (2002) Forward, relaxed, and reverse selection for reduced and enhanced sensitivity to ethanol’s locomotor stimulant effects in mice. Alcohol Clin Exp Res 26:593–602PubMedGoogle Scholar
  51. Pierce RC, Kalivas PW (1997) A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev 25:192–216PubMedCrossRefGoogle Scholar
  52. Rezvani AH, Overstreet DH, Yang Y, Maisonneuve IM, Bandarage UK, Kuehne ME, Glick SD (1997) Attenuation of alcohol consumption by a novel nontoxic ibogaine analogue (18-methoxycoronaridine) in alcohol-preferring rats. Pharmacol Biochem Behav 58:615–619PubMedCrossRefGoogle Scholar
  53. Romanelli MN, Gualtieri F (2003) Cholinergic nicotinic receptors: competitive ligands, allosteric modulators, and their potential applications. Med Res Rev 23:393–426PubMedCrossRefGoogle Scholar
  54. Salminen O, Murphy KL, McIntosh JM, Drago J, Marks MJ, Collins AC, Grady SR (2004) Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice. Mol Pharmacol 65:1526–1535PubMedCrossRefGoogle Scholar
  55. Schoffelmeer AN, De Vries TJ, Wardeh G, van de Ven HW, Vanderschuren LJ (2002) Psychostimulant-induced behavioral sensitization depends on nicotinic receptor activation. J Neurosci 22:3269–3276PubMedGoogle Scholar
  56. Shen EH, Harland RD, Crabbe JC, Phillips TJ (1995) Bidirectional selective breeding for ethanol effects on locomotor activity: characterization of FAST and SLOW mice through selection generation 35. Alcohol Clin Exp Res 19:1234–1245PubMedCrossRefGoogle Scholar
  57. Szumlinski KK, Balogun MY, Maisonneuve IM, Glick SD (2000a) Interactions between iboga agents and methamphetamine sensitization: studies of locomotion and stereotypy in rats. Psychopharmacology (Berl) 151:234–241CrossRefGoogle Scholar
  58. Szumlinski KK, McCafferty CA, Maisonneuve IM, Glick SD (2000b) Interactions between 18-methoxycoronaridine (18-MC) and cocaine: dissociation of behavioural and neurochemical sensitization. Brain Res 871:245–258PubMedCrossRefGoogle Scholar
  59. Young EM, Mahler S, Chi H, de Wit H (2005) Mecamylamine and ethanol preference in healthy volunteers. Alcohol Clin Exp Res 29:58–65PubMedCrossRefGoogle Scholar
  60. Zachariou V, Caldarone BJ, Weathers-Lowin A, George TP, Elsworth JD, Roth RH, Changeux JP, Picciotto MR (2001) Nicotine receptor inactivation decreases sensitivity to cocaine. Neuropsychopharmacology 24:576–589PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  1. 1.Department of Behavioral Neuroscience, Portland Alcohol Research Center, Methamphetamine Abuse Research CenterOregon Health & Science University and VA Medical CenterPortlandUSA
  2. 2.VA Medical Center Research Service, R&D 32PortlandUSA

Personalised recommendations